Interní Med. 2009; 11(12): 536-538

Prehypertension - a new disease?

MUDr.David Karásek, Ph.D., prof.MUDr.Helena Vaverková, CSc., doc.MUDr.Zdeněk Fryšák, CSc.
III. interní klinika LF UP a FN Olomouc

Prehypertension is defined as systolic blood pressure 120 to 139 or diastolic blood pressure 80 to 89 mm Hg, based on two or more properly

measured blood pressure readings on each of two or more office visits. The prevalence of prehypertension and of hypertension

is approximately the same in common population. Prehypertesion is associated with other risk factors for cardiovascular diseases and

with increased cardiovascular and all-cause mortality. Non-pharmacological intervention (dietary intervention, reduced sodium and

alcohol intake, weight loss, regular physical activity) is recommended for all people with prehypertension. Pharmacological therapy is

still established only for individuals with a high cardiovascular risk.

Keywords: prehypertension, hypertension, cardiovascular disease, obesity

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karásek D, Vaverková H, Fryšák Z. Prehypertension - a new disease? Interní Med. 2009;11(12):536-538.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chobanian AV, Bakris GL, Black HR, et al. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252. Go to original source... Go to PubMed...
    2. Mancia, G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. Erratum in: J Hypertens 2007; 25: 1749. Go to original source... Go to PubMed...
    3. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004; 164: 2113-2118. Go to original source... Go to PubMed...
    4. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines. Arch Intern Med 2004; 164: 2126-2134. Go to original source... Go to PubMed...
    5. Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-1686. Go to original source... Go to PubMed...
    6. Julius S, Nesbitt SD, Egan BM, et al. for the Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354: 1685-1697. Go to original source... Go to PubMed...
    7. Zhang Y, Lee ET, Devereux RB, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: The Strong Heart Study. Hypertension 2006; 47: 410-414. Go to original source... Go to PubMed...
    8. Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: Relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83: 1853-1859. Go to original source...
    9. Chrysohoou C, Pitsavos C, Panagiotakos DB, el al. Association between prehypertension status and inflammatory markers related to atherosclerotic disease. The ATTICA Study. Am J Hypertens. 2004; 17: 568-573. Go to original source... Go to PubMed...
    10. Papadopoulos DP, Makris TK, Krespi PG, et al. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens (Greenwich) 2005; 7: 729-733. Go to original source... Go to PubMed...
    11. Mainous AG, Everett CJ, Liszka H, et al. Prehypertension and mortality in a nationally representative cohort. Am J Cardiol 2004; 94: 1496-1500. Go to original source... Go to PubMed...
    12. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913. Go to original source... Go to PubMed...
    13. Lawes CM, Vander Hoorn S, Rodgers A. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513-1518. Go to original source... Go to PubMed...
    14. Hsia J, Margolis KL, Eaton CB, et al. For the women's health initiative investigators. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 2007; 115: 855-860. Go to original source... Go to PubMed...
    15. Toikka JO, Laine H, Ahotupa M, et al. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000; 36: 929-933. Go to original source... Go to PubMed...
    16. Washio M, Tokunaga S, Yoshimasu K, et al. Role of prehypertension in the development of coronary atherosclerosis in Japan. J Epidemiol 2004; 14: 57-62. Go to original source... Go to PubMed...
    17. Svetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med 1999; 159: 285-293. Go to original source... Go to PubMed...
    18. Svetkey LP. Management of prehypertension. Hypertension 2005; 45: 1056-1061. Go to original source... Go to PubMed...
    19. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-153. Go to original source... Go to PubMed...
    20. Giles TD, Berk BC, Black HR, et al. Expanding the definition and classification of hypertension. J Clin Hypertens (Greenwich) 2005; 7: 505-512. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.